These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 12413702)

  • 1. Comparative double-blind randomized placebo-controlled clinical trial of a herbal eye drop formulation (Qatoor Ramad) of Unani medicine in conjunctivitis.
    Siddiqui TA; Zafar S; Iqbal N
    J Ethnopharmacol; 2002 Nov; 83(1-2):13-7. PubMed ID: 12413702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative double masked randomised placebo controlled clinical trial of a herbal eye drop preparation in trachoma and conjunctivitis.
    Das GK; Pandey RM; Biswas NR
    J Indian Med Assoc; 1995 Oct; 93(10):383-4. PubMed ID: 9053413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of Ophthacare eye drops--a herbal formulation in the management of various ophthalmic disorders.
    Biswas NR; Gupta SK; Das GK; Kumar N; Mongre PK; Haldar D; Beri S
    Phytother Res; 2001 Nov; 15(7):618-20. PubMed ID: 11746845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective cohort trial of Euphrasia single-dose eye drops in conjunctivitis.
    Stoss M; Michels C; Peter E; Beutke R; Gorter RW
    J Altern Complement Med; 2000 Dec; 6(6):499-508. PubMed ID: 11152054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative double blind multicentric randomised placebo controlled clinical trial of a herbal preparation of eye drops in some ocular ailments.
    Biswas NR; Beri S; Das GK; Mongre PK
    J Indian Med Assoc; 1996 Mar; 94(3):101-2. PubMed ID: 8810206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the onset and duration of effect of azelastine eye drops (0.05%) versus placebo in patients with allergic conjunctivitis using an allergen challenge model.
    Friedlaender MH; Harris J; LaVallee N; Russell H; Shilstone J
    Ophthalmology; 2000 Dec; 107(12):2152-7. PubMed ID: 11097587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Azelastine eye-drops in seasonal allergic conjunctivitis or rhinoconjunctivitis. A double-blind, randomized, placebo-controlled study.
    Giede-Tuch C; Westhoff M; Zarth A
    Allergy; 1998 Sep; 53(9):857-62. PubMed ID: 9788686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Time to onset and duration of action of the antihistamine bepotastine besilate ophthalmic solutions 1.0% and 1.5% in allergic conjunctivitis: a phase III, single-center, prospective, randomized, double-masked, placebo-controlled, conjunctival allergen challenge assessment in adults and children.
    Abelson MB; Torkildsen GL; Williams JI; Gow JA; Gomes PJ; McNamara TR;
    Clin Ther; 2009 Sep; 31(9):1908-21. PubMed ID: 19843481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A double-blind crossover study comparing sodium cromoglycate eye drops with placebo in the treatment of chronic conjunctivitis.
    van Bijsterveld OP
    Acta Ophthalmol (Copenh); 1984 Jun; 62(3):479-84. PubMed ID: 6431741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized, double-masked, placebo-controlled parallel study of loteprednol etabonate 0.2% in patients with seasonal allergic conjunctivitis.
    Shulman DG; Lothringer LL; Rubin JM; Briggs RB; Howes J; Novack GD; Hart K
    Ophthalmology; 1999 Feb; 106(2):362-9. PubMed ID: 9951491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Besifloxacin ophthalmic suspension 0.6% in patients with bacterial conjunctivitis: A multicenter, prospective, randomized, double-masked, vehicle-controlled, 5-day efficacy and safety study.
    Karpecki P; Depaolis M; Hunter JA; White EM; Rigel L; Brunner LS; Usner DW; Paterno MR; Comstock TL
    Clin Ther; 2009 Mar; 31(3):514-26. PubMed ID: 19393842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Topical Antibiotics on Duration of Acute Infective Conjunctivitis in Children: A Randomized Clinical Trial and a Systematic Review and Meta-analysis.
    Honkila M; Koskela U; Kontiokari T; Mattila ML; Kristo A; Valtonen R; Sarlin S; Paalanne N; Ikäheimo I; Pokka T; Uhari M; Renko M; Tapiainen T
    JAMA Netw Open; 2022 Oct; 5(10):e2234459. PubMed ID: 36194412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose-dependent protection by azelastine eye drops against pollen-induced allergic conjunctivitis. A double-blind, placebo-controlled study.
    Horak F; Berger UE; Menapace R; Toth J; Stübner PU; Marks B
    Arzneimittelforschung; 1998 Apr; 48(4):379-84. PubMed ID: 9608880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of besifloxacin ophthalmic suspension 0.6% compared with moxifloxacin ophthalmic solution 0.5% for treating bacterial conjunctivitis.
    McDonald MB; Protzko EE; Brunner LS; Morris TW; Haas W; Paterno MR; Comstock TL; Usner DW
    Ophthalmology; 2009 Sep; 116(9):1615-1623.e1. PubMed ID: 19643483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of a pelargonium sidoides preparation in patients with the common cold: a randomized, double blind, placebo-controlled clinical trial.
    Lizogub VG; Riley DS; Heger M
    Explore (NY); 2007; 3(6):573-84. PubMed ID: 18005909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical evaluation of twice-daily emedastine 0.05% eye drops (Emadine eye drops) versus levocabastine 0.05% eye drops in patients with allergic conjunctivitis.
    Verin P; Easty DL; Secchi A; Ciprandi G; Partouche P; Nemeth-Wasmer G; Brancato R; Harrisberg CJ; Estivin-Ebrardt C; Coster DJ; Apel AJ; Coroneo MT; Knorr M; Carmichael TR; Kent-Smith BT; Abrantes P; Leonardi A; Cerqueti PM; Modorati G; Martinez M
    Am J Ophthalmol; 2001 Jun; 131(6):691-8. PubMed ID: 11384563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of the relative efficacy and clinical performance of olopatadine hydrochloride 0.1% ophthalmic solution and ketotifen fumarate 0.025% ophthalmic solution in the conjunctival antigen challenge model.
    Berdy GJ; Spangler DL; Bensch G; Berdy SS; Brusatti RC
    Clin Ther; 2000 Jul; 22(7):826-33. PubMed ID: 10945509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topical anti-inflammatory drugs in the treatment of allergic pollinosic conjunctivitis: a comparative double-blind study.
    Ciprandi G; Buscaglia S; Cerqueti MP; Saccà S; Tosca M; Canonica GW
    J Investig Allergol Clin Immunol; 1992; 2(5):248-52. PubMed ID: 1342906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topical indomethacin solution versus dexamethasone solution for treatment of inflamed pterygium and pinguecula: a prospective randomized clinical study.
    Frucht-Pery J; Siganos CS; Solomon A; Shvartzenberg T; Richard C; Trinquand C
    Am J Ophthalmol; 1999 Feb; 127(2):148-52. PubMed ID: 10030555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase 3 safety comparisons for 1.0% azithromycin in polymeric mucoadhesive eye drops versus 0.3% tobramycin eye drops for bacterial conjunctivitis.
    Protzko E; Bowman L; Abelson M; Shapiro A;
    Invest Ophthalmol Vis Sci; 2007 Aug; 48(8):3425-9. PubMed ID: 17652708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.